Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Mesoblast (MESO) over the last 11 years, with Q2 2025 value amounting to $1.3 million.

  • Mesoblast's Other Non-Current Assets fell 3834.44% to $1.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.3 million, marking a year-over-year decrease of 3834.44%. This contributed to the annual value of $1.3 million for FY2025, which is 3834.44% down from last year.
  • Latest data reveals that Mesoblast reported Other Non-Current Assets of $1.3 million as of Q2 2025, which was down 3834.44% from $1.3 million recorded in Q4 2024.
  • In the past 5 years, Mesoblast's Other Non-Current Assets registered a high of $3.2 million during Q1 2021, and its lowest value of $1.3 million during Q2 2025.
  • Moreover, its 5-year median value for Other Non-Current Assets was $2.0 million (2021), whereas its average is $2.0 million.
  • As far as peak fluctuations go, Mesoblast's Other Non-Current Assets tumbled by 4793.11% in 2021, and later soared by 2103.4% in 2023.
  • Over the past 5 years, Mesoblast's Other Non-Current Assets (Quarter) stood at $2.0 million in 2021, then fell by 1.74% to $1.9 million in 2022, then grew by 16.6% to $2.2 million in 2023, then plummeted by 40.52% to $1.3 million in 2024, then dropped by 2.78% to $1.3 million in 2025.
  • Its Other Non-Current Assets was $1.3 million in Q2 2025, compared to $1.3 million in Q4 2024 and $2.1 million in Q2 2024.